1
|
Schwartz MW, Seeley RJ, Zeltser LM,
Drewnowski A, Ravussin E, Redman LM and Leibel RL: Obesity
pathogenesis: An endocrine society scientific statement. Endocr
Rev. 38:267–296. 2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Karageorgi S, Alsmadi O and Behbehani K: A
review of adult obesity prevalence, trends, risk factors, and
epidemiologic methods in Kuwait. J Obes. 2013:3786502013.
View Article : Google Scholar
|
3
|
Rubinstein M and Low MJ: Molecular and
functional genetics of the proopiomelanocortin gene, food intake
regulation and obesity. FEBS Lett. 591:2593–2606. 2017. View Article : Google Scholar : PubMed/NCBI
|
4
|
Cristancho AG and Lazar MA: Forming
functional fat: A growing understanding of adipocyte
differentiation. Nat Rev Mol Cell Biol. 28:722–734. 2011.
View Article : Google Scholar
|
5
|
Farmer SR: Transcriptional control of
adipocyte formation. Cell Metab. 4:263–273. 2006. View Article : Google Scholar : PubMed/NCBI
|
6
|
Mota de Sá P, Richard AJ, Hang H and
Stephens JM: Transcriptional regulation of adipogenesis. Compr
Physiol. 7:635–674. 2017. View Article : Google Scholar : PubMed/NCBI
|
7
|
Guo L, Li X and Tang QQ: Transcriptional
regulation of adipo-cyte differentiation: A central role for
CCAAT/enhancer-binding protein (C/EBP) β. J Biol Chem. 290:755–761.
2015. View Article : Google Scholar
|
8
|
Ali AT, Hochfeld WE, Myburgh R and Pepper
MS: Adipocyte and adipogenesis. Eur J Cell Biol. 92:229–236. 2013.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Richard AJ and Stephens JM: The role of
JAK-STAT signaling in adipose tissue function. Biochim Biophys
Acta. 1842:431–439. 2014. View Article : Google Scholar :
|
10
|
Zhang K, Guo W, Yang Y and Wu J:
JAK2/STAT3 pathway is involved in the early stage of adipogenesis
through regulating C/EBPβ transcription. J Cell Biochem.
112:488–497. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Lenhard JM: Lipogenic enzymes as
therapeutic targets for obesity and diabetes. Curr Pharm Des.
17:325–331. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Peng IC, Chen Z, Sun W, Li YS, Marin TL,
Hsu PH, Su MI, Cui X, Pan S, Lytle CY, et al: Glucagon regulates
ACC activity in adipocytes through the CAMKKβ/AMPK pathway. Am J
Physiol Endocrinol Metab. 302:E1560–E1568. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Beller M, Bulankina AV, Hsiao HH, Urlaub
H, Jäckle H and Kühnlein RP: PERILIPIN-dependent control of lipid
droplet structure and fat storage in Drosophila. Cell Metab.
12:521–532. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Kern PA, Di Gregorio G, Lu T, Rassouli N
and Ranganathan G: Perilipin expression in human adipose tissue is
elevated with obesity. J Clin Endocrinol Metab. 89:1352–1358. 2004.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Martini CN, Plaza MV and Maria del Vila C:
PKA-dependent and independent cAMP signaling in 3T3-L1 fibroblasts
differentiation. Mol Cell Endocrinol. 298:42–47. 2009. View Article : Google Scholar
|
16
|
Yavari A, Stocker CJ, Ghaffari S, Wargent
ET, Steeples V, Czibik G, Pinter K, Bellahcene M, Woods A, Martínez
de Morentin PB, et al: Chronic activation of γ2 AMPK induces
obesity and reduces β cell function. Cell Metab. 23:821–836. 2016.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Prusty D, Park BH, Davis KE and Farmer SR:
Activation of MEK/ERK signaling promotes adipogenesis by enhancing
peroxi-some proliferator-activated receptor gamma (PPARgamma) and
C/EBPalpha gene expression during the differentiation of 3T3-L1
preadipocytes. J Biol Chem. 277:46226–46232. 2002. View Article : Google Scholar : PubMed/NCBI
|
18
|
Zhou Y, Wang D, Li F, Shi J and Song J:
Different roles of protein kinase C-betaI and -delta in the
regulation of adipocyte differentiation. Int J Biochem Cell Biol.
38:2151–2163. 2006. View Article : Google Scholar : PubMed/NCBI
|
19
|
Porras A, Muszynski K, Rapp UR and Santos
E: Dissociation between activation of Raf-1 kinase and the 42-kDa
mitogen-activated protein kinase/90-kDa S6 kinase (MAPK/RSK)
cascade in the insulin/Ras pathway of adipocytic differentiation of
3T3 L1 cells. J Biol Chem. 269:12741–12748. 1994.PubMed/NCBI
|
20
|
Kwak DH, Lee JH, Kim DG, Kim T, Lee KJ and
Ma JY: Inhibitory effects of hwangryunhaedok-tang in 3T3-L1
adipo-genesis by regulation of Raf/MEK1/ERK1/2 pathway and PDK1/Akt
phosphorylation. Evid Based Complement Alternat Med.
2013:4139062013. View Article : Google Scholar
|
21
|
Choi JS, Kim JH, Ali MY, Jung HJ, Min BS,
Choi RJ, Kim GD and Jung HA: Anti-adipogenic effect of epiberberine
is mediated by regulation of the Raf/MEK1/2/ERK1/2 and AMPKα/Akt
pathways. Arch Pharm Res. 38:2153–2162. 2015. View Article : Google Scholar : PubMed/NCBI
|
22
|
Henry JR, Kaufman MD, Peng SB, Ahn YM,
Caldwell TM, Vogeti L, Telikepalli H, Lu WP, Hood MM, Rutkoski TJ,
et al: Discovery of
1-(3,3-dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-m
ethyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea
(LY3009120) as a pan-RAF inhibitor with minimal paradoxical
activation and activity against BRAF or RAS mutant tumor cells. J
Med Chem. 58:4165–4179. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Peng SB, Henry JR, Kaufman MD, Lu WP,
Smith BD, Vogeti S, Rutkoski TJ, Wise S, Chun L, Zhang Y, et al:
Inhibition of RAF isoforms and active dimers by LY3009120 leads to
anti-tumor activities in RAS or BRAF mutant cancers. Cancer Cell.
28:384–398. 2015. View Article : Google Scholar : PubMed/NCBI
|
24
|
Woods A, Johnstone SR, Dickerson K, Leiper
FC, Fryer LG, Neumann D, Schlattner U, Wallimann T, Carlson M and
Carling D: LKB1 is the upstream kinase in the AMP-activated protein
kinase cascade. Cur Biol. 13:2004–2008. 2003. View Article : Google Scholar
|
25
|
Wang D, Zhou Y, Lei W, Zhang K, Shi J, Hu
Y, Shu G and Song J: Signal transducer and activator of
transcription 3 (STAT3) regulates adipocyte differentiation via
peroxisome-proliferator-activated receptor gamma (PPARgamma). Biol
Cell. 102:1–12. 2009. View Article : Google Scholar : PubMed/NCBI
|
26
|
Shang CA and Waters MJ: Constitutively
active signal transducer and activator of transcription 5 can
replace the requirement for growth hormone in adipogenesis of
3T3-F442A preadipocytes. Mol Endocrinol. 17:2494–2508. 2003.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Wolins NE, Brasaemle DL and Bickel PE: A
proposed model of fat packaging by exchangeable lipid droplet
proteins. FEBS Lett. 580:5484–5491. 2006. View Article : Google Scholar : PubMed/NCBI
|
28
|
Steinberg GR, Macaulay SL, Febbraio MA and
Kemp BE: AMP-activated protein kinase-the fat controller of the
energy railroad. Can J Physiol Pharmacol. 84:655–665. 2006.
View Article : Google Scholar : PubMed/NCBI
|
29
|
Lage R, Diéguez C, Vidal-Puig A and López
M: AMPK: A metabolic gauge regulating whole-body energy
homeostasis. Trends Mol Med. 14:539–549. 2008. View Article : Google Scholar : PubMed/NCBI
|
30
|
Han YH, Kee JY, Park J, Kim HL, Jeong MY,
Kim DS, Jeon YD, Jung Y, Youn DH, Kang J, et al: Arctigenin
inhibits adipogenesis by inducing AMPK activation and reduces
weight gain in high-fat diet-induced obese mice. J Cell Biochem.
117:2067–2077. 2016. View Article : Google Scholar : PubMed/NCBI
|
31
|
Vingtdeux V, Chandakkar P, Zhao H, Davies
P and Marambaud P: Small-molecule activators of AMP-activated
protein kinase (AMPK), RSVA314 and RSVA405, inhibit adipogenesis.
Mol Med. 17:1022–1030. 2011. View Article : Google Scholar : PubMed/NCBI
|
32
|
Baek JH, Kim NJ, Song JK and Chun KH:
Kahweol inhibits lipid accumulation and induces glucose-uptake
through activation of AMP-activated protein kinase (AMPK). BMB Rep.
50:566–571. 2017. View Article : Google Scholar : PubMed/NCBI
|
33
|
Zordoky BN, Nagendran J, Pulinilkunnil T,
Kienesberger PC, Masson G, Waller TJ, Kemp BE, Steinberg GR and
Dyck JR: AMPK-dependent inhibitory phosphorylation of ACC is not
essential for maintaining myocardial fatty acid oxidation. Circ
Res. 115:518–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
34
|
Saha AK and Ruderman NB: Malonyl-CoA and
AMP-activated protein kinase: An expanding partnership. Mol Cell
Biochem. 253:65–70. 2003. View Article : Google Scholar : PubMed/NCBI
|
35
|
Richter EA and Ruderman NB: AMPK and the
biochemistry of exercise: Implications for human health and
disease. Biochem J. 418:261–275. 2009. View Article : Google Scholar : PubMed/NCBI
|
36
|
Shaw RJ, Kosmatka M, Bardeesy N, Hurley
RL, Witters LA, DePinho RA and Cantley LC: The tumor suppressor
LKB1 kinase directly activates AMP-activated kinase and regulates
apoptosis in response to energy stress. Proc Natl Acad Sci USA.
101:3329–3335. 2004. View Article : Google Scholar : PubMed/NCBI
|
37
|
Xu Z, Liu J and Shan T: New roles of Lkb1
in regulating adipose tissue development and thermogenesis. J Cell
Physiol. 232:2296–2298. 2017. View Article : Google Scholar
|
38
|
Gormand A, Henriksson E, Ström K, Jensen
TE, Sakamoto K and Göransson O: Regulation of AMP-activated protein
kinase by LKB1 and CaMKK in adipocytes. J Cell Biochem.
112:1364–1375. 2011. View Article : Google Scholar : PubMed/NCBI
|
39
|
Hawley SA, Pan DA, Mustard KJ, Ross L,
Bain J, Edelmn AM, Frenguelli BG and Hardie DG: Calmodulin
dependent protein kinase kinase-beta is an alternative upstream
kinase for AMP-activated protein kinase. Cell Metab. 2:9–19. 2005.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Gowans GJ and Hardie DG: AMPK: A cellular
energy sensor primarily regulated by AMP. Biochem Soc Trans.
42:71–75. 2014. View Article : Google Scholar : PubMed/NCBI
|